Researcher Portfolio

 
   

Eibl, H.

Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society, Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society, Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society  

 

Researcher Profile

 
Position: Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society
Position: Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society
Position: Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society
Researcher ID: https://pure.mpg.de/cone/persons/resource/persons15029

External references

 

Publications

 
  (1 - 25 of 163)
 : Limmer, S., Hahn, J., Schmidt, R., Wachholz, K., Zengerle, A., Lechner, K., Eibl, H. J., Issels, R. D., Hossann, M., & Lindner, L. H. (2014). Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomes. Pharmaceutical Research, 31(9), 2276-2286. doi:10.1007/s11095-014-1322-6. [PubMan] : Rudner, J., Ruiner, C. E., Handrick, R., Eibl, H. J., Belka, C., & Jendrossek, V. (2010). The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation. Radiation Oncology, 5: 108. [PubMan] : Hossann, M., Wang, T. T., Wiggenhorn, M., Schmidt, R., Zengerle, A., Winter, G., Eibl, H. J., Peller, M., Reiser, M., Issels, R. D., & Lindner, L. H. (2010). Size of thermosensitive liposomes influences content release. Journal of Controlled Release, 147(3), 436-443. [PubMan] : Koenigs, S. K., Pallasch, C. P., Lindner, L. H., Schwamb, J., Schulz, A., Brinker, R., Claasen, J., Veldurthy, A., Eibl, H. J., Hallek, M., & Wendtner, C. M. (2010). Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathway. Leukemia Research: Interdisciplinary International, 34(8), 1064-1069. [PubMan] : Martelli, A. M., Papa, V., Tazzari, P. L., Ricci, F., Evangelisti, C., Chiarini, F., Grimaldi, C., Cappellini, A., Martinelli, G., Ottaviani, E., Pagliaro, P., Horn, S., Baesecke, J., Lindner, L. H., Eibl, H. J., & McCubrey, J. A. (2010). Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. Leukemia: the Journal of Normal and Malignant Hemopoiese; Official Journal of the Leukemia Research Fund U.K., 24(4), 687-698. [PubMan] : Henke, G., Lindner, L. H., Vogeser, M., Eibl, H. J., Woerner, J., Mueller, A. C., Bamberg, M., Wachholz, K., Belka, C., & Jendrossek, V. (2009). Pharmacokinetics and biodistribution of Erufosine in nude mice - implications for combination with radiotherapy. Radiation Oncology, 4(1): 46. Retrieved from http://www.ro-journal.com/content/pdf/1748-717X-4-46.pdf. [PubMan] : Papa, V., Tazzari, P., Chiarini, F., Ricci, F., Martinelli, G., Bontadini, A., McCubrey, J., Lindner, L. H., Eibl, H., & Martelli, A. M. (2008). Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, induces cell cycle arrest, apoptosis, and synergizes with chemotherapeutic drugs in acute myelogenous leukemia cells-a novel therapeutic approach for leukemia. Blood, 112(11), 480-480. [PubMan] : Fiegl, M., Lindner, L. H., Juergens, M., Eibl, H., Hiddemann, W., & Braess, J. (2008). Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs. Cancer Chemotherapy and Pharmacology, 62(2), 321-329. Retrieved from http://springerlink.metapress.com/content/v275q06mt983t646/fulltext.html. [PubMan] : Lindner, L. H., Eibl, H., Hossann, M., & Vogeser, M. (2008). Quantification of erufosine, the first intravenously applicable alkylphosphocholine, in human plasma by isotope dilution liquid chromatography–tandem mass spectrometry using a deuterated internal standard. Journal of Chromatography B, 869(1-2), 16-19. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6X0P-4SGD4TF-4-9&_cdi=7220&_user=38661&_orig=browse&_coverDate=06%2F15%2F2008&_sk=991309998&view=c&wchp=dGLbVlW-zSkzk&md5=54b94e6454b46c82d33b75ee7ccd4377&ie=/sdarticle.pdf. [PubMan] : Henke, G., Lindner, L. H., Vogeser, M., Eibl, H., Woerner, J., Bamberg, M., Belka, C., & Jendrossek, V. (2008). Pharmaceutical kinetics and bio-availability of Erufosine in the nude-mouse model. Strahlentherapie und Onkologie, 184(Suppl. 1), 122-122. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Belka, C., & Jendrossek, V. (2008). The combined effect of membrane operative apoptosis modulator and radiation therapy is dependent form mitochondrial cell death path. Strahlentherapie und Onkologie, 184(Suppl. 1), 50-50. [PubMan] : Wang, T., Hossann, M., Reinl, H. M., Peller, M., Eibl, H., Reiser, M., Issels, R. D., & Lindner, L. H. (2008). In vitro characterization of phosphatidylglyceroglycerol-based thermosensitive liposomes with encapsulated H-1 MR T-1-shortening gadodiamide. Contrast Media and Molecular Imaging, 3(1), 19-26. Retrieved from http://www3.interscience.wiley.com/cgi-bin/fulltext/117928885/PDFSTART. [PubMan] : Lindner, L. H., Hossann, M., Vogeser, M., Teichert, N., Wachholz, K., Eibl, H., Hiddemann, W., & Issels, R. (2008). Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release. Journal of Controlled Release, 125(2), 112-120. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T3D-4PYGVMN-2-2&_cdi=4944&_user=38661&_orig=search&_coverDate=01%2F22%2F2008&_sk=998749997&view=c&wchp=dGLbVlb-zSkWA&md5=52cd26757702fe9aa22b4418487875ce&ie=/sdarticle.pdf. [PubMan] : Hossann, M., Wiggenhorn, M., Schwerdt, A., Wachholz, K., Teichert, N., Eibl, H., Issels, R. D., & Lindner, L. H. (2007). In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochimica et Biophysica Acta-Biomembranes, 1768(10), 2491-2499. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T1T-4NWNCT1-1-C&_cdi=4899&_user=38661&_orig=browse&_coverDate=10%2F31%2F2007&_sk=982319989&view=c&wchp=dGLbVtz-zSkzS&md5=ab062670b347c074796defab714e9cdb&ie=/sdarticle.pdf. [PubMan] : Goebel, W., Obermeyer, N., Bleicher, N., Kratzmeier, M., Eibl, H., Doenecke, D., & Albig, W. (2007). Apoptotic DNA fragmentation is not related to the phosphorylation state of histone H1. Biological Chemistry, 388(2), 197-206. doi:10.1515/BC.2007.022. [PubMan] : Erdlenbruch, B., Preusse, A., Huelper, P., Kugler, W., Eibl, H., & Lakomek, M. (2006). Increased transfer of antibodiesto the CNS using BBB opening with 1-O-pentylglycerol and 2-O-hexyldiglycerol: Visualization of drug transfer using in vivo optical imaging. Neuro-Oncology, 8(4), 328-328. [PubMan] : Handrick, R., Ruebel, A., Faltin, H., Eibl, H., Belka, C., & Jendrossek, V. (2006). Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of protein kinase B/Akt-mediated survival-signaling. Radiotherapy and Oncology, 80(2), 199-206. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6TBY-4KNKBJK-7-9&_cdi=5155&_user=38661&_orig=browse&_coverDate=08%2F31%2F2006&_sk=999199997&view=c&wchp=dGLzVtb-zSkzV&md5=0b01e2c6afc90e49b9cfcd35098d3294&ie=/sdarticle.pdf. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Budach, W., Belka, C., & Jendrossek, V. (2006). Membrane-effective apoptosis modulators improve the radiation effect on cell lines of malignant gliomas in vitro: Influence on cell death- and survival signal paths. Strahlentherapie und Onkologie, 182(Suppl. 1), 85-85. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Budach, W., Belka, C., & Jendrossek, V. (2006). Increased cytotoxicity of ionizing radiation in combination with membrane-targeted apoptosis modulators involves downregulation of PKB/Akt-mediated survival signalling. Radiotherapy and Oncology, 78(Suppl. 1), S49-S49. [PubMan] : Lindner, L. H., Brock, R., Arndt-Jovin, D. J., & Eibl, H. (2006). Structural variation of cationic lipids: minimum requirement for improved oligonucleotide delivery into cells. Journal of Controlled Release, 110(2): 10.1016/j.jconrel.2005.10.009, pp. 444-456. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T3D-4HK5SG2-6-R&_cdi=4944&_user=38661&_orig=search&_coverDate=01%2F10%2F2006&_sk=998899997&view=c&wchp=dGLzVtb-zSkWz&md5=01be42df58bf5f0afde9239578a03c02&ie=/sdarticle.pdf. [PubMan] : Kugler, W., Buchholz, F., Koehler, F., Eibl, H., Lakomek, M., & Erdlenbruch, B. (2005). Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: Consequences for erucylphosphocholine-induced apoptosis. Apoptosis, 10(5), 1163-1174. Retrieved from http://springerlink.metapress.com/content/n2gjqk5172801j11/fulltext.pdf. [PubMan] : Handrick, R., Rudner, J., Mueller, I., Eibl, H., Belka, C., & Jendrossek, V. (2005). Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation. Biochemical Pharmacology, 70(6), 837-850. Retrieved from http://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T4P-4GSTP88-1-H&_cdi=4980&_user=38661&_orig=browse&_coverDate=09%2F15%2F2005&_sk=999299993&view=c&wchp=dGLbVtz-zSkWz&md5=ae511726c6b252cc99ab43f6441f68ec&ie=/sdarticle.pdf. [PubMan] : Ruebel, A., Handrick, R., Eibl, H., Belka, C., & Jendrossek, V. (2005). Influence of erucylphosphocholin on the sensitivity of glioblastoma cell lines opposite radiation-induced apoptosis. Strahlentherapie und Onkologie, 181(Suppl. 1), 103-104. [PubMan] : Handrick, R., Rudner, J., Mueller, I., Eibl, H., Belka, C., & Jendrossek, V. (2005). Importance of sub-cellular localisation of Bcl-2 for the protective effect against erucylphosphocholin-induced apoptosis. Strahlentherapie und Onkologie, 181(Suppl. 1), 104-104. [PubMan] : Erdlenbruch, B., Kugler, W., Schinkhof, C., Neurath, H., Eibl, H., & Lakomek, M. (2005). Blood-brain barrier opening with alkylglycerols: Biodistribution of 1-O-pentylglycerol after intravenous and intracarotid administration in rats. Journal of Drug Targeting, 13(3), 143-150. Retrieved from http://www.informaworld.com/smpp/ftinterface~content=a713728741~fulltext=713240928. [PubMan]